Evidence map›Paper›PMID 32968046›Full record

ArticleCell death & disease2020

USP29 enhances chemotherapy-induced stemness in non-small cell lung cancer via stabilizing Snail1 in response to oxidative stress.

Yueguang Wu, Yingqiu Zhang, Duchuang Wang, Yang Zhang, Jinrui Zhang, Yayun Zhang, Lu Xu, Taishu Wang, Shanshan Wang, Qingqing Zhang and 9 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Role of Ubiquitin-regulated EMT in Cancer Metastasis and Chemoresistance.International journal of biological sciences · 2025
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Survivin degradation by bergenin overcomes pemetrexed resistance.Cellular oncology (Dordrecht, Netherlands) · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 2 countries.

Yueguang Wu *The Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Yingqiu Zhang *The Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Duchuang WangThe Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Yang ZhangThe Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Jinrui ZhangThe Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Yayun ZhangThe Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Lu XuThe Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Taishu WangThe Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Shanshan WangThe Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Qingqing ZhangDepartment of Pathology, Dalian Medical University, Dalian, China.
Fang LiuThe Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Mohamed Y ZakyThe Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Qiong LiThe Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Qianhui SunThe Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Dong GuoThe Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Shuyan LiuThe Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Lijuan ZouThe Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China. zoulijuan1963@sina.com.
Qingkai YangThe Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China. yangqingkai@dmu.edu.cn.
Han LiuThe Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China. liuhan@dmu.edu.cn.ORCID http://orcid.org/0000-0002-0014-4675
Dalian Medical University · CNBeni-Suef University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemotherapy remains an essential part of diverse treatment regimens against human malignancies. However, recent progressions have revealed a paradoxical role of chemotherapies to induce the cancer stem cell-like features that facilitate chemoresistance and tumor dissemination, with the underlying mechanisms underinvestigated. The zinc-finger transcription factor Snail1 is a central regulator during the epithelial-mesenchymal transition process and is closely implicated in cancer progression. Snail1 expression is strictly regulated at multiple layers, with its stability governed by post-translational ubiquitylation that is counterbalanced by the activities of diverse E3 ligases and deubiquitylases. Here we identify the deubiquitylase USP29 as a novel stabilizer of Snail1, which potently restricts its ubiquitylation in a catalytic activity-dependent manner. Bioinformatic analysis reveals a reverse correlation between USP29 expression and prognosis in lung adenocarcinoma patients. USP29 is unique among Snail1 deubiquitylases through exhibiting chemotherapy-induced upregulation. Mechanistically, oxidative stresses incurred by chemotherapy stimulate transcriptional activation of USP29. USP29 upregulation enhances the cancer stem cell-like characteristics in lung adenocarcinoma cells to promote tumorigenesis in athymic nude mice. Our findings uncover a novel mechanism by which chemotherapy induces cancer stemness and suggest USP29 as a potential therapeutic target to impede the development of chemoresistance and metastasis in lung adenocarcinoma.

Indexed as

AnimalsCarcinoma, Non-Small-Cell LungCell Line, TumorFemaleHumansLung NeoplasmsMiceMice, NudeOxidative StressSnail Family Transcription FactorsTransfectionUbiquitin-Specific ProteasesSnail Family Transcription FactorsUbiquitin-Specific ProteasesUsp29 protein, mouse

Identifiers

PMID32968046
PMCPMC7511960
OpenAlexW3088885461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.